Cover Image
Market Research Report
Product code 
1076321

Insulin Delivery Devices Market Size, Share & Trends Analysis Report By Product (Insulin Syringes, Insulin Pens, Insulin Pumps, Insulin Injectors), By End Use (Hospitals, Homecare), By Region, And Segment Forecasts, 2022 - 2030

Published: | Grand View Research, Inc. | 120 Pages | Delivery time: 2-10 business days

Price

Back to Top
Insulin Delivery Devices Market Size, Share & Trends Analysis Report By Product (Insulin Syringes, Insulin Pens, Insulin Pumps, Insulin Injectors), By End Use (Hospitals, Homecare), By Region, And Segment Forecasts, 2022 - 2030
Published: April 5, 2022
Grand View Research, Inc.
Content info: 120 Pages
Delivery time: 2-10 business days
  • Description
  • Table of Contents
  • List of Tables

Insulin Delivery Devices Market Growth & Trends:

The global insulin delivery devices market size is expected to reach USD 27.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.4% from 2022 to 2030. Obesity, sedentary lifestyles, and unhealthy food habits, primarily in the young population, lead to the occurrence of diabetes. In addition, the growing diabetic geriatric population is another factor supporting the growth of this vertical. According to the United Nations, Department of Economic and Social Affairs, around 901 million individuals were aged 60 or over in 2015 and this number is projected to increase to 1.4 billion by 2030. Thus, the enlarging elderly population is expected to boost the demand for insulin delivery devices.

Technological innovations and advancements are an ongoing trend in this vertical. The high demand for advanced insulin delivery devices is supporting the adoption of recently launched innovative pen devices and portable pumps, which is estimated to boost the market growth. Also, favorable reimbursement policies for these devices, mainly in developed countries like the U.S. and Germany, are anticipated to fuel the market growth during the study period. However, stringent regulatory requirements regulating the approval of insulin delivery devices and the high cost of insulin analogs in diabetes care management are major factors restraining the growth of this industry.

The market's prominent competitors are taking different initiatives such as acquisition, funding, and product development to expand their product portfolio and enhance their manufacturing capacity. For instance, in October 2021, Eli Lilly partnered with Cipla, to market its Insulin products (Humalog and Trulicity) in India. Additionally, In June 2021, the company acquired Protomer Technologies, to strengthen its market presence. Further, Novo Nordisk, joined hands with Biocorp to develop a Bluetooth-enabled smart add-on device for their pen insulin injector.

Insulin Delivery Devices Market Report Highlights:

  • The insulin pens segment was the largest revenue-generating category of this market in 2021. The pen is equipped with self-contained cartridges and offers ease in handling and less pain while injecting insulin. The advantages of these pen devices over other products are resulting in their growing popularity, thus serving as a vital factor in contributing to the sector's highest share in this market
  • The home care segment is estimated to be the fastest-growing segment due to increased adoption of self-care diabetes management devices and the availability of simplified and user-friendly product designs for patients
  • North America is the leading regional sector and accounted for the largest revenue share in 2021 primarily due to the favorable reimbursement scenario in this space. Also, the presence of major manufacturers in this region is supporting market growth
  • In Asia Pacific, the market is anticipated to grow fast during the forecast period. The high prevalence rate of diabetes in countries, such as China and India, is a major factor contributing to market expansion in this region
Product Code: GVR-1-68038-991-3

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. End use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Insulin Delivery Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increasing prevalence of diabetes
      • 3.4.1.2. Favorable government reimbursement scenario
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. High cost of insulin products
  • 3.5. Insulin Delivery Devices Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Insulin Delivery Devices Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Insulin syringes
    • 4.1.2. Insulin pens
    • 4.1.3. Insulin pumps
    • 4.1.4. Insulin injectors
  • 4.2. Product Market Share, 2018 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Insulin Delivery Devices Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Insulin syringes
      • 4.5.1.1. Insulin syringes market estimates and forecast, 2018 to 2030 (USD Million)
    • 4.5.2. Insulin pens
      • 4.5.2.1. Insulin pens market estimates and forecast, 2018 to 2030 (USD Million)
    • 4.5.3. Insulin pumps
      • 4.5.3.1. Insulin pumps market estimates and forecast, 2018 to 2030 (USD Million)
    • 4.5.4. Insulin injectors
      • 4.5.4.1. Insulin injectors market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 5. Insulin Delivery Devices Market: End-use Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Hospitals
    • 5.1.2. Homecare
    • 5.1.3. Others
  • 5.2. End Use Market Share, 2018 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Insulin Delivery Devices Market by End Use Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Hospitals
      • 5.5.1.1. Hospitals estimates and forecast, 2018 to 2030 (USD Million)
    • 5.5.2. Home care
      • 5.5.2.1. Home care market estimates and forecast, 2018 to 2030 (USD Million)
    • 5.5.3. Others
      • 5.5.3.1. Others market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 6. Insulin Delivery Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Regional market share analysis, 2018 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Regional Market Share and Leading Players
    • 6.4.1. North America
    • 6.4.2. Europe
    • 6.4.3. Asia Pacific
    • 6.4.4. Latin America
    • 6.4.5. Middle East and Africa
  • 6.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 6.5.1. North America
    • 6.5.2. Europe
    • 6.5.3. Asia Pacific
    • 6.5.4. Latin America
    • 6.5.5. Middle East and Africa
  • 6.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030
  • 6.7. North America
    • 6.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.2. U.S.
      • 6.7.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.3. Canada
      • 6.7.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.8. Europe
    • 6.8.1. U.K.
      • 6.8.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.8.2. Germany
      • 6.8.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.9. Asia Pacific
    • 6.9.1. China
      • 6.9.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.9.2. India
      • 6.9.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.10. Latin America
    • 6.10.1. Brazil
      • 6.10.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.10.2. Mexico
      • 6.10.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.11. MEA
    • 6.11.1. South Africa
      • 6.11.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis
    • 7.3.4. Novo Nordisk A/S
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Sanofi
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Eli Lilly and Company
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Biocon Ltd.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Ypsomed AG
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Wockhardt Ltd.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Medtronic
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Abbott Laboratories
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. F. Hoffmann-La Roche, Ltd.
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
  • Table 4 North America Insulin Delivery Devices Market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
  • Table 8 Canada Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Europe Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
  • Table 10 Europe Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe Insulin Delivery Devices Market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
  • Table 13 Germany Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
  • Table 14 U.K. Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
  • Table 15 U.K. Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
  • Table 16 APAC Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
  • Table 17 APAC Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
  • Table 18 APAC Insulin Delivery Devices Market, by region, 2018 - 2030 (USD Million)
  • Table 19 China Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
  • Table 20 China Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
  • Table 21 India Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
  • Table 22 India Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Latin America Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
  • Table 24 Latin America Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Latin America Insulin Delivery Devices Market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
  • Table 27 Brazil Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Mexico Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
  • Table 29 Mexico Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
  • Table 31 Middle East and Africa Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Middle East and Africa Insulin Delivery Devices Market, by region, 2018 - 2030 (USD Million)
  • Table 33 South Africa Insulin Delivery Devices Market, by product, 2018 - 2030 (USD Million)
  • Table 34 South Africa Insulin Delivery Devices Market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Insulin Delivery Devices Market: market outlook
  • Fig. 14 Insulin Delivery Devices Market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Insulin Delivery Devices Market driver impact
  • Fig. 20 Insulin Delivery Devices Market restraint impact
  • Fig. 21 Insulin Delivery Devices Market strategic initiatives analysis
  • Fig. 22 Insulin Delivery Devices Market: product movement analysis
  • Fig. 23 Insulin Delivery Devices Market: product outlook and key takeaways
  • Fig. 24 Insulin syringes market estimates and forecast, 2018 - 2030
  • Fig. 25 Insulin pens market estimates and forecast, 2018 - 2030
  • Fig. 26 Insulin pumps market estimates and forecast, 2018 - 2030
  • Fig. 27 Insulin injectors market estimates and forecast, 2018 - 2030
  • Fig. 28 Insulin Delivery Devices Market: end-use movement analysis
  • Fig. 29 Insulin Delivery Devices Market: end-use outlook and key takeaways
  • Fig. 30 Hospitals market estimates and forecast, 2018 - 2030
  • Fig. 31 Homecare centers market estimates and forecast, 2018 - 2030
  • Fig. 32 Others market estimates and forecast, 2018 - 2030
  • Fig. 33 Global Insulin Delivery Devices Market: regional movement analysis
  • Fig. 34 Global Insulin Delivery Devices Market: regional outlook and key takeaways
  • Fig. 35 Global market share and leading players
  • Fig. 36 North America market share and leading players
  • Fig. 37 Europe market share and leading players
  • Fig. 38 Asia Pacific market share and leading players
  • Fig. 39 Latin America market share and leading players
  • Fig. 40 Middle East & Africa market share and leading players
  • Fig. 41 North America: SWOT
  • Fig. 42 Europe SWOT
  • Fig. 43 Asia Pacific SWOT
  • Fig. 44 Latin America SWOT
  • Fig. 45 MEA SWOT
  • Fig. 46 North America, by country
  • Fig. 47 North America
  • Fig. 48 North America market estimates and forecast, 2018 - 2030
  • Fig. 49 U.S.
  • Fig. 50 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 51 Canada
  • Fig. 52 Canada market estimates and forecast, 2018 - 2030
  • Fig. 53 Europe
  • Fig. 54 Europe market estimates and forecast, 2018 - 2030
  • Fig. 55 U.K.
  • Fig. 56 U.K. market estimates and forecast, 2018 - 2030
  • Fig. 57 Germany
  • Fig. 58 Germany market estimates and forecast, 2018 - 2030
  • Fig. 59 Asia Pacific
  • Fig. 60 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 61 China
  • Fig. 62 China market estimates and forecast, 2018 - 2030
  • Fig. 63 India
  • Fig. 64 India market estimates and forecast, 2018 - 2030
  • Fig. 65 Latin America
  • Fig. 66 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 67 Brazil
  • Fig. 68 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 69 Mexico
  • Fig. 70 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 71 Middle East and Africa
  • Fig. 72 Middle East and Africa market estimates and forecast, 2018 - 2030
  • Fig. 73 South Africa
  • Fig. 74 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 75 Participant categorization- Insulin Delivery Devices Market
  • Fig. 76 Market share of key market players- Insulin Delivery Devices Market